Comparison

brilanestrant

Item no. V2995-500mg
Manufacturer InvivoChem LLC
CASRN 1365888-06-7
Amount 500mg
Category
Type Biochemicals
Specific against other
ECLASS 10.1 32160490
ECLASS 11.0 32160490
UNSPSC 12000000
Available
Description
InvivoChem Cat #:V2995CAS #:1365888-06-7Purity >=98%

Description: Brilanestrant (formerly known as GDC-0810, ARN-810 and/or RG6046) is a novel, potent and orally bioavailable Selective Estrogen Receptor Degrader (SERD) that demonstrates robust activity in models of tamoxifen-sensitive and tamoxifen-resistant breast cancer, and is currently in clinical trials in women with locally advanced or metastatic estrogen receptor-positive breast cancer.tamoxifen-resistant breast cancer xenografts. GDC-0810 induces a distinct ERalpha conformation versus tamoxifen and other ER therapeutics, and does not exhibit tamoxifen-like ER agonism in MCF7 cells.

Description:

References: 2016 Jul 13; 5. pii: e15828; 2015 Jun 25; 58(12):4888-904.

References:


Molecular Weight (MW)
446.9
Formula
C26H20ClFN2O2
CAS No.
1365888-06-7
Storage
-20C for 3 years in powder form
-80C for 2 years in solvent
Solubility (In vitro)
DMSO: >= 30 mg/mL
Water: < 1 mg/mL
Ethanol: < 1 mg/mL
Solubility (In vivo)
O=C(O)/C=C/C1=CC=C(C=C1)/C(C2=CC3=C(NN=C3)C=C2)=C(CC)\C4=CC=C(C=C4Cl)F
Synonyms
RG6046; RG-6046; RG 6046; ARN810; ARN 810; ARN-810; GDC0810; GDC 0810; GDC-0810

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 500mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close